Markus Flepp

8.4k citations
76 papers · 5.8k · 4 hit papers · h-index 35

Impact in

  • Virology top 0.2%
    • HIV Research and Treatment
    • HIV/AIDS Research and Interventions
    • HIV/AIDS drug development and treatment

Papers in

    • HIV/AIDS drug development and treatment 30
    • HIV/AIDS Research and Interventions 19
    • HIV Research and Treatment 21

Markus Flepp

73 papers receiving 5.5k citations

Markus Flepp's Hit Papers

Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study 2012 · 285 citations
2850+9+19Years since publication250500750

Peers

Markus Flepp
Comparison fields: 5 of 126
  • Virology 1.9k
  • Infectious Diseases 3.1k
  • Emergency Medicine 805
  • Hepatology 673
  • Epidemiology 1.5k
Replace Donna Mildvan with:
Donna Mildvan United States
John Bartlett United States
François Raffi France
P. Dellamonica France
Shinichi Oka Japan
Gilles Pialoux France
Sharon Walmsley Canada
Jack Fuhrer United States
Harold A. Kessler United States
Sophie Matheron France
Markus Flepp relative to Donna Mildvan United States Donna Mildvan's profile →
Citations per field
00.5×1.6×
Donna Mildvan · 1×
Citations per year

Countries citing papers authored by Markus Flepp

Since Specialization
Citations

This map shows the geographic impact of Markus Flepp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Flepp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Flepp more than expected).

Fields of papers citing papers by Markus Flepp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Flepp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Flepp. The network helps show where Markus Flepp may publish in the future.

Co-authors

The 25 scholars most cited alongside Markus Flepp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Flepp Line = papers co-authored together Markus Flepp links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study
Hit paper breakdown →
1999783
2
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
Hit paper breakdown →
2000713
3
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study
Hit paper breakdown →
1997506
4
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study
Hit paper breakdown →
2012285
5 2001273
6 2000216
7 2008208
8 2001187
9 1999187
10 2001174
11
Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study.
1999144
12 1997135
13 2002111
14 1985107
15 1985107
16 1997101
17 200994
18 200393
19
Heat-mediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reaction.
199674
20 200074

About Markus Flepp

Markus Flepp is a scholar working on Infectious Diseases, Virology, Epidemiology, Emergency Medicine and Oncology, having authored 76 papers that have together received 5.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (30 papers), HIV Research and Treatment (21 papers), HIV/AIDS Research and Interventions (19 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers), HIV-related health complications and treatments (7 papers), Hepatitis C virus research (4 papers), Viral-associated cancers and disorders (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). The work is most often cited by research in Virology (1.9k citations), Infectious Diseases (3.1k citations), Emergency Medicine (805 citations), Hepatology (673 citations) and Epidemiology (1.5k citations). Markus Flepp has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Pietro Vernazza, Amalio Telenti, Bernard Hirschel, Hansjakob Furrer, P Francioli, Bruno Ledergerber, Martin Rickenbach, Matthias Egger, Philippe Sudre and Rainer Weber. Their work appears in journals such as AIDS, Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, The Lancet and JAIDS Journal of Acquired Immune Deficiency Syndromes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact